북미의 마이크로바이옴 샘플 조제 기술 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 워크플로우별, 용도별, 질환별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

North America Microbiome Sample Preparation Technology Market Growth & Trends:

The North America microbiome sample preparation technology market size is expected to reach USD 152.1 million by 2030 and is anticipated to grow at a CAGR of 6.1% from 2025 to 2030. The increasing adoption of precision medicine across clinical and research settings accelerates the demand for microbiome-based insights. Healthcare providers and researchers use microbiome data to design targeted therapies, particularly for chronic illnesses and metabolic disorders. This trend toward personalized treatment strategies boosts the need for accurate and efficient sample preparation technologies. High-throughput sequencing workflows depend on precise sample handling to maintain data integrity, driving the uptake of advanced preparation kits and automation tools. A strong focus on reproducibility and quality in scientific research further amplifies the demand for standardized processing methods. As a result, sample preparation technologies are becoming essential to the growing microbiome research ecosystem.

Another significant driver is the expanding application of microbiome studies in the pharmaceutical and biotechnology sectors. Companies are investing in microbiome-based drug development, focusing on therapies for gastrointestinal, neurological, and autoimmune conditions. To support these efforts, firms require scalable and consistent sample preparation platforms to handle large volumes of complex biological specimens. The rise in clinical trials involving microbiome interventions intensifies the need for robust technologies that minimize variability and contamination. Additionally, partnerships between research institutes and industry players accelerate innovation in preparation tools and protocols. These collaborations are enhancing the overall efficiency and accuracy of microbiome analysis workflows.

Technological advancements in automation and workflow integration are further contributing to market expansion. Laboratories are moving toward fully integrated systems that combine extraction, purification, and quality control in a single platform. These solutions save time, reduce manual errors, and improve throughput, making them highly attractive to academic and commercial labs. As data complexity increases, there is a growing requirement for software and instruments that ensure consistency from sample to sequencing. The emergence of user-friendly, high-performance systems is supporting wider adoption among non-specialist users. This trend enables more institutions to conduct in-house microbiome research, driving sustained demand for sample preparation technologies across North America.

North America Microbiome Sample Preparation Technology Market Report Highlights:

• Based on product, the consumables segment is expected to witness the fastest growth at a CAGR of 6.23% during the forecast period. This is due to the increasing demand for high-throughput and accurate microbiome analysis. Expansion of laboratory networks across the U.S. and Canada has further supported the rising consumption of single-use preparation products.
• Based on workflow, the sample extraction/isolation segment dominated the market and accounted for the largest revenue share of 21.7% in 2024, driven by the critical need for high-quality microbial DNA and RNA in downstream applications. Strong presence of key players offering advanced extraction tools has reinforced segment leadership in the region.
• Based on application, the DNA sequencing segment dominated the market and accounted for the largest revenue share in 2024, driven by the rapid adoption of next-generation sequencing platforms in microbiome research.
• Based on disease, the gastrointestinal disorders segment dominated the market. It accounted for the largest revenue share in 2024, driven by the growing recognition of the gut microbiome's role in chronic disease progression. In North America, healthcare providers and research institutes invest heavily in understanding gut microbial imbalance.
• Based on end use, the diagnostic labs segment held the largest revenue share in 2024, driven by the expansion of clinical microbiome testing services across North America. Demand for accurate microbial profiling in disease diagnosis has prompted labs to adopt specialized sample preparation technologies.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Workflow
  • 1.2.3. Application
  • 1.2.4. Disease
  • 1.2.5. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. North America Microbiome Sample Preparation Technology Market Variables & Trends

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Advancements in Microbiome-Based Therapeutics and Research
    • 3.2.1.2. Expanding Use of Multi-Omics Approaches
    • 3.2.1.3. Rising Demand for Precision Medicine
    • 3.2.1.4. Adoption of Automation & AI
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of Standardization in Sample Preparation Protocols
    • 3.2.2.2. High Cost of Instruments and Limited Skilled Workforce
• 3.3. North America Microbiome Sample Preparation Technology Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. North America Microbiome Sample Preparation Technology Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. North America Microbiome Sample Preparation Technology Market Product Movement Analysis
• 4.3. North America Microbiome Sample Preparation Technology Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Consumables
  • 4.4.1. Consumables Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.4.2. Purification/Extraction Kits
    • 4.4.2.1. Purification/Extraction Kits Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.4.3. Library prep kits
    • 4.4.3.1. Library prep kits Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.3.2. DNA Library Preparation Kits
      • 4.4.3.2.1. DNA Library Preparation Kits Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.3.3. RNA Library Preparation Kits
      • 4.4.3.3.1. RNA Library Preparation Kits Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.3.4. Library Quantitation & Amplification kits
      • 4.4.3.4.1. Library Quantitation & Amplification kits Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.3.5. Clean-up and Selection Kits
      • 4.4.3.5.1. Clean-up and Selection Kits Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.3.6. Microbiome DNA Enrichment
      • 4.4.3.6.1. Microbiome DNA Enrichment Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
    • 4.4.3.7. Others
      • 4.4.3.7.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 4.5. Instruments
  • 4.5.1. Instruments Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5.2. Workstation
    • 4.5.2.1. Workstation Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5.3. Extraction System
    • 4.5.3.1. Extraction System Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5.4. Liquid Handling Instrument
    • 4.5.4.1. Liquid Handling Instrument Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5.5. Other Sample Preparation Instruments
    • 4.5.5.1. Other Sample Preparation Instruments Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 5. North America Microbiome Sample Preparation Technology Market: Workflow Estimates & Trend Analysis

• 5.1. Workflow Segment Dashboard
• 5.2. North America Microbiome Sample Preparation Technology Market Workflow Movement Analysis
• 5.3. North America Microbiome Sample Preparation Technology Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
• 5.4. Sample Extraction/Isolation
  • 5.4.1. Sample Extraction/Isolation Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 5.5. Library Preparation
  • 5.5.1. Library Preparation Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 5.6. Sample Quantification
  • 5.6.1. Sample Quantification Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 5.7. Fragmentation
  • 5.7.1. Fragmentation Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 5.8. Target Enrichment
  • 5.8.1. Target Enrichment Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 5.9. Quality Control
  • 5.9.1. Quality Control Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 5.10. Pooling
  • 5.10.1. Pooling Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 5.11. Library Quantification
  • 5.11.1. Library Quantification Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)

Chapter 6. North America Microbiome Sample Preparation Technology Market: Application Estimates & Trend Analysis

• 6.1. Application Segment Dashboard
• 6.2. North America Microbiome Sample Preparation Technology Market Application Movement Analysis
• 6.3. North America Microbiome Sample Preparation Technology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. DNA Sequencing
  • 6.4.1. DNA Sequencing Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 6.5. RNA Sequencing
  • 6.5.1. RNA Sequencing Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 6.6. Methylation Sequencing
  • 6.6.1. Methylation Sequencing Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 6.7. Single Cell Sequencing
  • 6.7.1. Single Cell Sequencing Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 6.8. Whole-Genome Sequencing
  • 6.8.1. Whole-Genome Sequencing Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 6.9. Metagenomics
  • 6.9.1. Metagenomics Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 6.10. Others
  • 6.10.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)

Chapter 7. North America Microbiome Sample Preparation Technology Market: Disease Estimates & Trend Analysis

• 7.1. Disease Segment Dashboard
• 7.2. North America Microbiome Sample Preparation Technology Market Disease Movement Analysis
• 7.3. North America Microbiome Sample Preparation Technology Market Size & Trend Analysis, by Disease, 2018 to 2030 (USD Million)
• 7.4. Gastrointestinal Disorders
  • 7.4.1. Gastrointestinal Disorders Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 7.5. Autoimmune Disorder
  • 7.5.1. Autoimmune Disorder Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 7.6. Cancer
  • 7.6.1. Cancer Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 7.7. Others
  • 7.7.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)

Chapter 8. North America Microbiome Sample Preparation Technology Market: End Use Estimates & Trend Analysis

• 8.1. End Use Segment Dashboard
• 8.2. North America Microbiome Sample Preparation Technology Market End Use Movement Analysis
• 8.3. North America Microbiome Sample Preparation Technology Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 8.4. Diagnostic Labs
  • 8.4.1. Diagnostic Labs Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 8.5. Pharmaceutical & Biotechnology
  • 8.5.1. Pharmaceutical & Biotechnology Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)
• 8.6. Others
  • 8.6.1. Others Market Size & Forecasts and Trend Analyses, 2018 to 2030, (USD Million)

Chapter 9. North America Microbiome Sample Preparation Technology Market: Country Estimates & Trend Analysis

• 9.1. Country Market Share Analysis, 2024 & 2030
• 9.2. Country Market Dashboard
• 9.3. U.S.
  • 9.3.1. Key country dynamics
  • 9.3.2. Regulatory framework
  • 9.3.3. Competitive scenario
  • 9.3.4. U.S. market estimates and forecasts 2018 to 2030, (USD Million)
• 9.4. Canada
  • 9.4.1. Key country dynamics
  • 9.4.2. Regulatory framework
  • 9.4.3. Competitive scenario
  • 9.4.4. Canada market estimates and forecasts 2018 to 2030, (USD Million)
• 9.5. Mexico
  • 9.5.1. Key country dynamics
  • 9.5.2. Regulatory framework
  • 9.5.3. Competitive scenario
  • 9.5.4. Mexico market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Participant Categorization
• 10.2. Company Market Position Analysis, 2024
• 10.3. Strategy Mapping
• 10.4. Participants Overview
  • 10.4.1. QIAGEN
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. BGI
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Bio-Rad Laboratories, Inc.
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. Perkin Elmer, Inc.
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. Agilent Technologies Inc.
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. Illumina, Inc.
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. F. Hoffmann-La Roche Ltd.
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. Danaher Corporation
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product benchmarking
    • 10.4.8.4. Strategic initiatives